FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Linda Wyatt

Research Profile

Living Beings

Chemicals & Drugs

Disorders

Simian Acquired Immunodeficiency Syndrome

Anatomy

Co-author Network

Publications

TOP 3
Kylie M Quinn; Mario Roederer; Lingshu Wang; Linda S Wyatt; Ayako Yamamoto; Robert T Bailer; Dana Berry; Cheng Cheng; Stefano Colloca; Riccardo Cortese; Andreia Da Costa; Patricia A Darrah; Mariano Esteban; Antonella Folgori; Jason G D Gall; Carmen E Gomez; Emma Gostick; Wing-Pui Kong; Richard A Koup; Ross W B Lindsay; Cecilia Morgan; Bernard Moss; Gary Nabel; Alfredo Nicosia; David A Price; Robert A Seder
Comparative analysis of the magnitude, quality, phenotype, and protective capacity of simian immunodeficiency virus gag-specific CD8+ T cells following human-, simian-, and chimpanzee-derived recombinant adenoviral vector immunization.
Kaori Shinoda; Linda S Wyatt; Bernard Moss
The neutralizing antibody response to the vaccinia virus A28 protein is specifically enhanced by its association with the H2 protein.
Linda S Wyatt; Patricia L Earl; Wei Xiao; Jeffrey L Americo; Catherine A Cotter; Jennifer Vogt; Bernard Moss
Elucidating and minimizing the loss by recombinant vaccinia virus of human immunodeficiency virus gene expression resulting from spontaneous mutations and positive selection.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Linda Wyatt (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Kylie M Quinn; Mario Roederer; Lingshu Wang; Linda S Wyatt; Ayako Yamamoto; Robert T Bailer; Dana Berry; Cheng Cheng; Stefano Colloca; Riccardo Cortese; Andreia Da Costa; Patricia A Darrah; Mariano Esteban; Antonella Folgori; Jason G D Gall; Carmen E Gomez; Emma Gostick; Wing-Pui Kong; Richard A Koup; Ross W B Lindsay; Cecilia Morgan; Bernard Moss; Gary Nabel; Alfredo Nicosia; David A Price; Robert A Seder
Comparative analysis of the magnitude, quality, phenotype, and protective capacity of simian immunodeficiency virus gag-specific CD8+ T cells following human-, simian-, and chimpanzee-derived recombinant adenoviral vector immunization.
Journal of immunology (Baltimore, Md. : 1950) 2013;190(6):2720-35.
2010: Kaori Shinoda; Linda S Wyatt; Bernard Moss
The neutralizing antibody response to the vaccinia virus A28 protein is specifically enhanced by its association with the H2 protein.
Virology 2010;405(1):41-9.
2009: Linda S Wyatt; Patricia L Earl; Wei Xiao; Jeffrey L Americo; Catherine A Cotter; Jennifer Vogt; Bernard Moss
Elucidating and minimizing the loss by recombinant vaccinia virus of human immunodeficiency virus gene expression resulting from spontaneous mutations and positive selection.
Journal of virology 2009;83(14):7176-84.
2009: Jun Zhao; Lilin Lai; Rama Rao Amara; David C Montefiori; Francios VILLINGER; Lakshmi Chennareddi; Linda S Wyatt; Bernard Moss; Harriet L Robinson
Preclinical studies of human immunodeficiency virus/AIDS vaccines: inverse correlation between avidity of anti-Env antibodies and peak postchallenge viremia.
Journal of virology 2009;83(9):4102-11.
2009: Kaori Shinoda; Linda S Wyatt; Kari R Irvine; Bernard Moss
Engineering the vaccinia virus L1 protein for increased neutralizing antibody response after DNA immunization.
Virology journal 2009;6():28.
2008: Patricia L Earl; Jeffrey L Americo; Linda S Wyatt; Ondraya Espenshade; Jocelyn Bassler; Kathy Gong; Shuling Lin; Elizabeth Peters; Lowrey Rhodes; Yvette Edghill Spano; Peter M Silvera; Bernard Moss
Rapid protection in a monkeypox model by a single injection of a replication-deficient vaccinia virus.
Proceedings of the National Academy of Sciences of the United States of America 2008;105(31):10889-94.
2008: Tatiana G Senkevich; Linda S Wyatt; Andrea S Weisberg; Eugene V Koonin; Bernard Moss
A conserved poxvirus NlpC/P60 superfamily protein contributes to vaccinia virus virulence in mice but not to replication in cell culture.
Virology 2008;374(2):506-14.
2008: Linda S Wyatt; Igor M Belyakov; Patricia L Earl; Jay A Berzofsky; Bernard Moss
Enhanced cell surface expression, immunogenicity and genetic stability resulting from a spontaneous truncation of HIV Env expressed by a recombinant MVA.
Virology 2008;372(2):260-72.
2008: Linda S Wyatt; Patricia L Earl; Jennifer Vogt; Leigh Anne Eller; Dev Chandran; Jinyan Liu; Harriet L Robinson; Bernard Moss
Correlation of immunogenicities and in vitro expression levels of recombinant modified vaccinia virus Ankara HIV vaccines.
Vaccine 2008;26(4):486-93.
2008: D Huw Davies; Linda S Wyatt; Frances K Newman; Patricia L Earl; Sookhee Chun; Jenny E Hernandez; Douglas M Molina; Siddiqua Hirst; Bernard Moss; Sharon E Frey; Philip L Felgner
Antibody profiling by proteome microarray reveals the immunogenicity of the attenuated smallpox vaccine modified vaccinia virus ankara is comparable to that of Dryvax.
Journal of virology 2008;82(2):652-63.
2007: Lilin Lai; Dalma Vödrös; Pamela A Kozlowski; David C Montefiori; Robert L Wilson; Vicki L Akerstrom; Lakshmi Chennareddi; Tianwei Yu; Sunil Kannanganat; Lazarus Ofielu; Francios VILLINGER; Linda S Wyatt; Bernard Moss; Rama Rao Amara; Harriet L Robinson
GM-CSF DNA: an adjuvant for higher avidity IgG, rectal IgA, and increased protection against the acute phase of a SHIV-89.6P challenge by a DNA/MVA immunodeficiency virus vaccine.
Virology 2007;369(1):153-67.
2007: Harriet L Robinson; Sunita Sharma; Jun Zhao; Sunil Kannanganat; Lilin Lai; Lakshmi Chennareddi; Tianwei Yu; David C Montefiori; Rama Rao Amara; Linda S Wyatt; Bernard Moss
Immunogenicity in macaques of the clinical product for a clade B DNA/MVA HIV vaccine: elicitation of IFN-gamma, IL-2, and TNF-alpha coproducing CD4 and CD8 T cells.
AIDS research and human retroviruses 2007;23(12):1555-62.
2007: Pragati Nigam; Patricia L Earl; Jeffrey L Americo; Sunita Sharma; Linda S Wyatt; Yvette Edghill-Spano; Lakshmi Chennareddi; Peter Silvera; Bernard Moss; Harriet L Robinson; Rama Rao Amara
DNA/MVA HIV-1/AIDS vaccine elicits long-lived vaccinia virus-specific immunity and confers protection against a lethal monkeypox challenge.
Virology 2007;366(1):73-83.
2007: Patricia L Earl; Jeffrey L Americo; Linda S Wyatt; Leigh Anne Eller; David C Montefiori; Russ Byrum; Michael Piatak; Jeffrey D Lifson; Rama Rao Amara; Harriet L Robinson; John W Huggins; Bernard Moss
Recombinant modified vaccinia virus Ankara provides durable protection against disease caused by an immunodeficiency virus as well as long-term immunity to an orthopoxvirus in a non-human primate.
Virology 2007;366(1):84-97.
2007: Jinyan Liu; Michael Hellerstein; Michael McDonnel; Rama Rao Amara; Linda S Wyatt; Bernard Moss; Harriet L Robinson
Dose-response studies for the elicitation of CD8 T cells by a DNA vaccine, used alone or as the prime for a modified vaccinia Ankara boost.
Vaccine 2007;25(15):2951-8.
2006: Harriet L Robinson; David C Montefiori; Francios VILLINGER; James E Robinson; Sunita Sharma; Linda S Wyatt; Patricia L Earl; Harold M McClure; Bernard Moss; Rama Rao Amara
Studies on GM-CSF DNA as an adjuvant for neutralizing Ab elicited by a DNA/MVA immunodeficiency virus vaccine.
Virology 2006;352(2):285-94.
2006: Dennis Ellenberger; Ron A Otten; Bin Li; Michael Aidoo; I Vanessa Rodriguez; Carlos A Sariol; Melween Martinez; Michael Monsour; Linda S Wyatt; Michael G Hudgens; Edmundo Kraiselburd; Bernard Moss; Harriet Robinson; Thomas M Folks; Salvatore T Butera
HIV-1 DNA/MVA vaccination reduces the per exposure probability of infection during repeated mucosal SHIV challenges.
Virology 2006;352(1):216-25.
2006: Jinyan Liu; Linda S Wyatt; Rama Rao Amara; Bernard Moss; Harriet L Robinson
Studies on in vitro expression and in vivo immunogenicity of a recombinant MVA HIV vaccine.
Vaccine 2006;24(16):3332-9.
2005: Dennis Ellenberger; Linda S Wyatt; Bin Li; Suzan Buge; Nattawan Lanier; I Vanesssa Rodriguez; Carlos A Sariol; Melween Martinez; Michael Monsour; Jennifer Vogt; James Smith; Ron A Otten; David Montefiori; Edmundo Kraiselburd; Bernard Moss; Harriet Robinson; Janet M McNicholl; Salvatore T Butera
Comparative immunogenicity in rhesus monkeys of multi-protein HIV-1 (CRF02_AG) DNA/MVA vaccines expressing mature and immature VLPs.
Virology 2005;340(1):21-32.
2005: Shanmugalakshmi Sadagopal; Rama Rao Amara; David C Montefiori; Linda S Wyatt; Silvija I Staprans; Natalia Kozyr; Harold M McClure; Bernard Moss; Harriet L Robinson
Signature for long-term vaccine-mediated control of a Simian and human immunodeficiency virus 89.6P challenge: stable low-breadth and low-frequency T-cell response capable of coproducing gamma interferon and interleukin-2.
Journal of virology 2005;79(6):3243-53.
2005: James M Smith; Rama Rao Amara; Linda S Wyatt; Dennis Ellenberger; Bin Li; James G. Herndon; Milloni Patel; Sunita Sharma; Lakshmi Chennareddi; Salvatore T Butera; Janet M McNicholl; Harold M McClure; Bernard Moss; Harriet L Robinson
Studies in macaques on cross-clade T cell responses elicited by a DNA/MVA AIDS vaccine, better conservation of CD8 than CD4 T cell responses.
AIDS research and human retroviruses 2005;21(2):140-4.
2004: James M Smith; Rama Rao Amara; David Campbell; Yan Xu; Milloni Patel; Sunita Sharma; Salvatore T Butera; Dennis Ellenberger; Hong Yi; Lakshmi Chennareddi; James G. Herndon; Linda S Wyatt; David Montefiori; Bernard Moss; Harold M McClure; Harriet L Robinson
DNA/MVA vaccine for HIV type 1: effects of codon-optimization and the expression of aggregates or virus-like particles on the immunogenicity of the DNA prime.
AIDS research and human retroviruses 2004;20(12):1335-47.
2004: James M Smith; Rama Rao Amara; Harold M McClure; Milloni Patel; Sunita Sharma; Hong Yi; Lakshmi Chennareddi; James G. Herndon; Salvatore T Butera; Walid Heneine; Dennis Ellenberger; Bharat Parekh; Patricia L Earl; Linda S Wyatt; Bernard Moss; Harriet L Robinson
Multiprotein HIV type 1 clade B DNA/MVA vaccine: construction, safety, and immunogenicity in Macaques.
AIDS research and human retroviruses 2004;20(6):654-65.
2004: Linda S Wyatt; Patricia L Earl; Jin Yan Liu; James M Smith; David C Montefiori; Harriet L Robinson; Bernard Moss
Multiprotein HIV type 1 clade B DNA and MVA vaccines: construction, expression, and immunogenicity in rodents of the MVA component.
AIDS research and human retroviruses 2004;20(6):645-53.
2004: Linda S Wyatt; Patricia L Earl; Leigh Anne Eller; Bernard Moss
Highly attenuated smallpox vaccine protects mice with and without immune deficiencies against pathogenic vaccinia virus challenge.
Proceedings of the National Academy of Sciences of the United States of America 2004;101(13):4590-5.
2004: Patricia L Earl; Jeffrey L Americo; Linda S Wyatt; Leigh Anne Eller; J Charles Whitbeck; Gary H Cohen; Roselyn J Eisenberg; Christopher J Hartmann; David L Jackson; David A Kulesh; Mark J Martinez; David M Miller; Eric Mucker; Joshua D Shamblin; Susan H Zwiers; John W Huggins; Peter B Jahrling; Bernard Moss
Immunogenicity of a highly attenuated MVA smallpox vaccine and protection against monkeypox.
Nature 2004;428(6979):182-5.
2003: Suzan L Buge; Hak-Ling Ma; Rama Rao Amara; Linda S Wyatt; Patricia L Earl; Francios VILLINGER; David C Montefiori; Silvija I Staprans; Yan Xu; Eddye Carter; Shawn P O'Neil; James G. Herndon; Elizabeth Hill; Bernard Moss; Harriet L Robinson; Janet M McNicholl
Gp120-alum boosting of a Gag-Pol-Env DNA/MVA AIDS vaccine: poorer control of a pathogenic viral challenge.
AIDS research and human retroviruses 2003;19(10):891-900.
2003: Zhi-Yong Yang; Linda S Wyatt; Wing-Pui Kong; Zoe Moodie; Bernard Moss; Gary Nabel
Overcoming immunity to a viral vaccine by DNA priming before vector boosting.
Journal of virology 2003;77(1):799-803.
2002: Jamal Baig; Daniel B Levy; Paul F McKay; Joern schmitz; Sampa Santra; Ramu A Subbramanian; Marcelo J Kuroda; Michelle A Lifton; Darci A Gorgone; Linda S Wyatt; Bernard Moss; Yue Huang; Bimal K Chakrabarti; Ling Xu; Wing-Pui Kong; Zhi-Yong Yang; John R Mascola; Gary Nabel; Angela Carville; Andrew Lackner; Ronald S Veazey; Norman L Letvin
Elicitation of simian immunodeficiency virus-specific cytotoxic T lymphocytes in mucosal compartments of rhesus monkeys by systemic vaccination.
Journal of virology 2002;76(22):11484-90.
2002: Rama Rao Amara; Francios VILLINGER; Silvija I Staprans; John D Altman; David C Montefiori; Natalia Kozyr; Yan Xu; Linda S Wyatt; Patricia L Earl; James G. Herndon; Harold M McClure; Bernard Moss; Harriet L Robinson
Different patterns of immune responses but similar control of a simian-human immunodeficiency virus 89.6P mucosal challenge by modified vaccinia virus Ankara (MVA) and DNA/MVA vaccines.
Journal of virology 2002;76(15):7625-31.
2002: Sampa Santra; Dan H Barouch; Marcelo J Kuroda; Joern schmitz; Georgia R Krivulka; Kristin Beaudry; Carol I Lord; Michelle A Lifton; Linda S Wyatt; Bernard Moss; Vanessa M Hirsch; Norman L Letvin
Prior vaccination increases the epitopic breadth of the cytotoxic T-lymphocyte response that evolves in rhesus monkeys following a simian-human immunodeficiency virus infection.
Journal of virology 2002;76(12):6376-81.
2002: Rama Rao Amara; James M Smith; Silvija I Staprans; David C Montefiori; Francios VILLINGER; John D Altman; Shawn P O'Neil; Natalia Kozyr; Yan Xu; Linda S Wyatt; Patricia L Earl; James G. Herndon; Janet M McNicholl; Harold M McClure; Bernard Moss; Harriet L Robinson
Critical role for Env as well as Gag-Pol in control of a simian-human immunodeficiency virus 89.6P challenge by a DNA prime/recombinant modified vaccinia virus Ankara vaccine.
Journal of virology 2002;76(12):6138-46.
2002: Rama Rao Amara; Francios VILLINGER; John D Altman; Shari L Lydy; Shawn P O'Neil; Silvija I Staprans; David C Montefiori; Yan Xu; James G. Herndon; Linda S Wyatt; Maria Angelito Candido; Natalia Kozyr; Patricia L Earl; James M Smith; Hak-Ling Ma; Bennett D Grimm; Michael L Hulsey; Harold M McClure; Janet M McNicholl; Bernard Moss; Harriet L Robinson
Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine.
Vaccine 2002;20(15):1949-55.
2002: Patricia L Earl; Linda S Wyatt; David C Montefiori; Miroslawa Bilska; ruth woodward; Phillip D Markham; James D Malley; Thorsten U Vogel; Todd M Allen; David Ian Watkins; Nancy Miller; Bernard Moss
Comparison of vaccine strategies using recombinant env-gag-pol MVA with or without an oligomeric Env protein boost in the SHIV rhesus macaque model.
Virology 2002;294(2):270-81.
2001: Dan H Barouch; Sampa Santra; Marcelo J Kuroda; Joern schmitz; Ronald Plishka; Alicia Buckler-White; A E Gaitan; R Zin; J H Nam; Linda S Wyatt; Michelle A Lifton; Christine E Nickerson; Bernard Moss; David C Montefiori; Vanessa M Hirsch; Norman L Letvin
Reduction of simian-human immunodeficiency virus 89.6P viremia in rhesus monkeys by recombinant modified vaccinia virus Ankara vaccination.
Journal of virology 2001;75(11):5151-8.
2001: Patricia L Earl; Bernard Moss; Linda S Wyatt; M W Carroll
Generation of recombinant vaccinia viruses.
Current protocols in protein science / editorial board, John E. Coligan ... [et al.] 2001;Chapter 5():Unit5.13.
2001: Patricia L Earl; N Cooper; Linda S Wyatt; Bernard Moss; M W Carroll
Preparation of cell cultures and vaccinia virus stocks.
Current protocols in protein science / editorial board, John E. Coligan ... [et al.] 2001;Chapter 5():Unit5.12.
2001: Patricia L Earl; Bernard Moss; Linda S Wyatt; M W Carroll
Generation of recombinant vaccinia viruses.
Current protocols in molecular biology / edited by Frederick M. Ausubel ... [et al.] 2001;Chapter 16():Unit16.17.
2001: Patricia L Earl; N Cooper; Linda S Wyatt; Bernard Moss; M W Carroll
Preparation of cell cultures and vaccinia virus stocks.
Current protocols in molecular biology / edited by Frederick M. Ausubel ... [et al.] 2001;Chapter 16():Unit16.16.
2001: Rama Rao Amara; Francios VILLINGER; John D Altman; Shari L Lydy; Shawn P O'Neil; Silvija I Staprans; David C Montefiori; Yan Xu; James G. Herndon; Linda S Wyatt; Maria Angelito Candido; Natalia Kozyr; Patricia L Earl; James M Smith; Hak-Ling Ma; Bennett D Grimm; Michael L Hulsey; J Miller; Harold M McClure; Janet M McNicholl; Bernard Moss; Harriet L Robinson
Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine.
Science (New York, N.Y.) 2001;292(5514):69-74.
2001: Dan H Barouch; A Craiu; Sampa Santra; Michael A Egan; Joern schmitz; Marcelo J Kuroda; Tong-Ming Fu; J H Nam; Linda S Wyatt; Michelle A Lifton; Georgia R Krivulka; Christine E Nickerson; Carol I Lord; Bernard Moss; Mark G Lewis; Vanessa M Hirsch; John W Shiver; Norman L Letvin
Elicitation of high-frequency cytotoxic T-lymphocyte responses against both dominant and subdominant simian-human immunodeficiency virus epitopes by DNA vaccination of rhesus monkeys.
Journal of virology 2001;75(5):2462-7.
2000: Ilnour Ourmanov; Charles R Brown; Bernard Moss; M Carroll; Linda S Wyatt; L Pletneva; Simoy Goldstein; D Venzon; Vanessa M Hirsch
Comparative efficacy of recombinant modified vaccinia virus Ankara expressing simian immunodeficiency virus (SIV) Gag-Pol and/or Env in macaques challenged with pathogenic SIV.
Journal of virology 2000;74(6):2740-51.
2000: Aruna Seth; Ilnour Ourmanov; Joern schmitz; Marcelo J Kuroda; Michelle A Lifton; Christine E Nickerson; Linda S Wyatt; M Carroll; Bernard Moss; D Venzon; Norman L Letvin; Vanessa M Hirsch
Immunization with a modified vaccinia virus expressing simian immunodeficiency virus (SIV) Gag-Pol primes for an anamnestic Gag-specific cytotoxic T-lymphocyte response and is associated with reduction of viremia after SIV challenge.
Journal of virology 2000;74(6):2502-9.
1999: Linda S Wyatt; S S Whitehead; K A Venanzi; Brian Murphy; Bernard Moss
Priming and boosting immunity to respiratory syncytial virus by recombinant replication-defective vaccinia virus MVA.
Vaccine 1999;18(5-6):392-7.
1998: Linda S Wyatt; M W Carroll; C P Czerny; M Merchlinsky; J R Sisler; Bernard Moss
Marker rescue of the host range restriction defects of modified vaccinia virus Ankara.
Virology 1998;251(2):334-42.
1998: Aruna Seth; Ilnour Ourmanov; Marcelo J Kuroda; Joern schmitz; M W Carroll; Linda S Wyatt; Bernard Moss; MA Forman; Vanessa M Hirsch; Norman L Letvin
Recombinant modified vaccinia virus Ankara-simian immunodeficiency virus gag pol elicits cytotoxic T lymphocytes in rhesus monkeys detected by a major histocompatibility complex class I/peptide tetramer.
Proceedings of the National Academy of Sciences of the United States of America 1998;95(17):10112-6.
1996: Linda S Wyatt; S T Shors; Brian Murphy; Bernard Moss
Development of a replication-deficient recombinant vaccinia virus vaccine effective against parainfluenza virus 3 infection in an animal model.
Vaccine 1996;14(15):1451-8.
1996: G C Katsafanas; E C Schirmer; Linda S Wyatt; Niza Frenkel
In vitro activation of human herpesviruses 6 and 7 from latency.
Proceedings of the National Academy of Sciences of the United States of America 1996;93(18):9788-92.
1996: Bernard Moss; MW Carroll; Linda S Wyatt; Jack R Bennink; Vanessa M Hirsch; S Goldstein; W R Elkins; Thomas R Fuerst; Jeffrey D Lifson; M Piatak; Nicholas P Restifo; Willem W Overwijk; R Chamberlain; STEVEN ROSENBERG; G Sutter
Host range restricted, non-replicating vaccinia virus vectors as vaccine candidates.
Advances in experimental medicine and biology 1996;397():7-13.
1995: Linda S Wyatt; Bernard Moss; S Rozenblatt
Replication-deficient vaccinia virus encoding bacteriophage T7 RNA polymerase for transient gene expression in mammalian cells.
Virology 1995;210(1):202-5.
1995: J L Sever; Tamara A Rakusan; M Ellaurie; Niza Frenkel; Linda S Wyatt; J M Campos; R M O'Donnell; M V Price
Coinfection with herpesviruses in young children of HIV-infected women.
Pediatric AIDS and HIV infection 1995;6(2):75-82.
1994: Niza Frenkel; G C Katsafanas; Linda S Wyatt; T Yoshikawa; Y Asano
Bone marrow transplant recipients harbor the B variant of human herpesvirus 6.
Bone marrow transplantation 1994;14(5):839-43.
1994: G Sutter; Linda S Wyatt; P L Foley; Jack R Bennink; Bernard Moss
A recombinant vector derived from the host range-restricted and highly attenuated MVA strain of vaccinia virus stimulates protective immunity in mice to influenza virus.
Vaccine 1994;12(11):1032-40.
1994: J C Burns; J W Newburger; R Sundell; Linda S Wyatt; Niza Frenkel
Seroprevalence of human herpesvirus 7 in patients with Kawasaki disease.
The Pediatric infectious disease journal 1994;13(2):168-9.
1993: Tetsushi Yoshikawa; Yoshizo Asano; I Kobayashi; T Nakashima; T Yazaki; Sadao Suga; T Ozaki; Linda S Wyatt; Niza Frenkel
Seroepidemiology of human herpesvirus 7 in healthy children and adults in Japan.
Journal of medical virology 1993;41(4):319-23.
1992: Linda S Wyatt; Niza Frenkel
Human herpesvirus 7 is a constitutive inhabitant of adult human saliva.
Journal of virology 1992;66(5):3206-9.
1992: Niza Frenkel; Linda S Wyatt
HHV-6 and HHV-7 as exogenous agents in human lymphocytes.
Developments in biological standardization 1992;76():259-65.
1991: Linda S Wyatt; W J Rodriguez; N Balachandran; Niza Frenkel
Human herpesvirus 7: antigenic properties and prevalence in children and adults.
Journal of virology 1991;65(11):6260-5.
1991: E C Schirmer; Linda S Wyatt; K Yamanishi; W J Rodriguez; Niza Frenkel
Differentiation between two distinct classes of viruses now classified as human herpesvirus 6.
Proceedings of the National Academy of Sciences of the United States of America 1991;88(13):5922-6.
1990: Linda S Wyatt; N Balachandran; Niza Frenkel
Variations in the replication and antigenic properties of human herpesvirus 6 strains.
The Journal of infectious diseases 1990;162(4):852-7.
1990: Niza Frenkel; E C Schirmer; Linda S Wyatt; G Katsafanas; E Roffman; R M Danovich; C H June
Isolation of a new herpesvirus from human CD4+ T cells.
Proceedings of the National Academy of Sciences of the United States of America 1990;87(2):748-52.
1990: Niza Frenkel; E Roffman; E C Schirmer; G Katsafanas; Linda S Wyatt; C H June
Cellular and growth-factor requirements for the replication of human herpesvirus 6 in primary lymphocyte cultures.
Advances in experimental medicine and biology 1990;278():1-8.